SUN PHARMACEUTICAL INDUSTRIES
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹15,119 Cr | ₹13,752 Cr | ₹11,088 Cr | ₹9,408 Cr | ₹4,481 Cr |
| Adjustment | ₹882 Cr | ₹1,120 Cr | ₹1,554 Cr | ₹2,723 Cr | ₹1,975 Cr |
| Changes In working Capital | ₹-1,268 Cr | ₹-324 Cr | ₹1,062 Cr | ₹-5,662 Cr | ₹1,559 Cr |
| Cash Flow after changes in Working Capital | ₹14,733 Cr | ₹14,549 Cr | ₹13,704 Cr | ₹6,469 Cr | ₹8,015 Cr |
| Cash Flow from Operating Activities | ₹12,419 Cr | ₹14,072 Cr | ₹12,135 Cr | ₹4,959 Cr | ₹8,985 Cr |
| Cash Flow from Investing Activities | ₹-11,344 Cr | ₹-5,306 Cr | ₹-690 Cr | ₹-7,944 Cr | ₹-5,725 Cr |
| Cash Flow from Financing Activities | ₹-2,513 Cr | ₹-7,906 Cr | ₹-6,710 Cr | ₹2,376 Cr | ₹-5,193 Cr |
| Net Cash Inflow / Outflow | ₹-1,437 Cr | ₹860 Cr | ₹4,735 Cr | ₹-608 Cr | ₹-1,934 Cr |
| Opening Cash & Cash Equivalents | ₹10,269 Cr | ₹9,286 Cr | ₹4,624 Cr | ₹4,508 Cr | ₹6,273 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | ₹163 Cr | ₹-0.03 Cr | ₹1.29 Cr | ₹567 Cr | ₹41 Cr |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹776 Cr | ₹123 Cr | ₹-74 Cr | ₹157 Cr | ₹127 Cr |
| Closing Cash & Cash Equivalent | ₹9,771 Cr | ₹10,269 Cr | ₹9,286 Cr | ₹4,624 Cr | ₹4,508 Cr |
Compare Cashflow Statement of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,704.1 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,472.0 Cr | -2.4% | 1.2% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.8% |
3.5% |
14.7% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses